Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML
Clinical trial NCT02942758 · TERMINATED
Trial details
- NCT number
- NCT02942758
- Sponsor
- University Hospital Regensburg
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-10
- Primary completion
- 2020-03-25
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.